About CancerVax
CancerVax is a company based in Carlsbad (United States) founded in 1998.. CancerVax has raised $58 million across 3 funding rounds from investors including J P Morgan, GE Capital and China Developement Bank. CancerVax operates in a competitive market with competitors including Helsinn, Aster Insights, Abogen Biosciences, OnCusp and Oncotherapeutics, among others.
- Headquarter Carlsbad, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$58 M (USD)
in 3 rounds
-
Latest Funding Round
$1 M (USD), Unspecified
Oct 13, 2023
-
Investors
J P Morgan
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CancerVax
CancerVax has successfully raised a total of $58M across 3 strategic funding rounds. The most recent funding activity was a Unspecified round of $1 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Unspecified — $1.0M
-
First Round
First Round
(01 Apr 2002)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Unspecified - CancerVax | Valuation |
investors |
|
| Jun, 2023 | Amount | Unspecified - CancerVax | Valuation |
investors |
|
| Apr, 2002 | Amount | Series C - CancerVax | Valuation | Athenian Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CancerVax
CancerVax has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include J P Morgan, GE Capital and China Developement Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused early stage venture capital firm
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on early-stage healthcare startups
|
Founded Year | Domain | Location | |
|
Life Sciences & Offline focused early stage VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CancerVax
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CancerVax
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cancervax Comparisons
Competitors of CancerVax
CancerVax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, Abogen Biosciences, OnCusp and Oncotherapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| domain | founded_year | HQ Location |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| domain | founded_year | HQ Location |
CRO offering clinical development services for oncology drugs
|
|
| domain | founded_year | HQ Location |
Preclinical and clinical oncology drug development services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cancervax
Frequently Asked Questions about CancerVax
When was CancerVax founded?
CancerVax was founded in 1998 and raised its 1st funding round 4 years after it was founded.
Where is CancerVax located?
CancerVax is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Who is the current CEO of CancerVax?
David Hale is the current CEO of CancerVax.
Is CancerVax a funded company?
CancerVax is a funded company, having raised a total of $58M across 3 funding rounds to date. The company's 1st funding round was a Series C of $55M, raised on Apr 01, 2002.
What does CancerVax do?
CancerVax was established in 1998 and is based in Carlsbad, United States. Operations are centered in the biotechnology sector, specifically oncology and immunotherapy. Focus is placed on developing vaccines targeted at cancer treatment. Research activities are led from the companys headquarters, with David Hale serving as CEO. Limited public details are available regarding specific products or partnerships.
Who are the top competitors of CancerVax?
Who are CancerVax's investors?
CancerVax has 12 investors. Key investors include J P Morgan, GE Capital, China Developement Bank, Athenian Venture Partners, and SV Health Investors.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.